Gut Microbiome and Retinopathy of Prematurity

Area of Science:

• Neonatal ophthalmology
• Microbiome research
• Pediatric health

Background:

• Retinopathy of prematurity (ROP) is a major cause of childhood blindness, linked to premature birth.
• Many preterm infants do not develop ROP, suggesting other contributing factors.
• The neonatal gut microbiome is dynamic and can be disrupted by prematurity.

Purpose of the Study:

• To explore the potential role of the early gut microbiome in retinopathy of prematurity (ROP) pathophysiology.
• To review the literature on the gut-retina axis and its implications for ROP.
• To identify potential mechanisms linking the gut microbiome to ROP development.

Main Methods:

• Literature review of studies on ROP, neonatal gut microbiome, and the gut-retina axis.
• Analysis of potential mechanisms involving dysregulated growth factors (VEGF, IGF-1).
• Examination of how ROP risk factors (hypoxia, sepsis, antibiotics) impact the gut microbiome.

Main Results:

• Prematurity is associated with gut dysbiosis and conditions like necrotizing enterocolitis.
• Evidence supports a gut-retina axis influencing ROP.
• Known ROP risk factors can alter the gut microbiome composition.

Conclusions:

• The early intestinal environment, specifically the gut microbiome, may play a significant role in ROP.
• Further research into the gut-retina axis is warranted to understand ROP pathogenesis.
• Targeting the gut microbiome could offer novel therapeutic avenues for preventing ROP.